Approvals/TGA/ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 210mg powder for injection vial with diluent vial

Approved

STANDARD

ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 210mg powder for injection vial with diluent vial

Pharmaco Australia Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: bdad497fda9fac56
Product Name: ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 210mg powder for injection vial with diluent vial
Artg Id: 143658
Artg Name: ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 210mg powder for injection vial with diluent vial
Sponsor: Pharmaco Australia Ltd
Artg Date: 2009-03-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/920deb88dbd88b49c765f8ff54af7da7.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/bee682f243ff852a55bdd03b716381f2.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

bdad497fda9fac56

Type

Standard